Preventing maternal deaths due to acquired thrombotic thrombocytopenic purpura

被引:7
作者
Hunt, Beverley J. [1 ]
Thomas-Dewing, Rowena R. [1 ]
Bramham, Kate [3 ]
Lucas, Sebastian B. [2 ]
机构
[1] Guys & St Thomas Hosp NHS Fdn Trust, Dept Thrombosis & Haemostasis, London, England
[2] Guys & St Thomas Hosp NHS Fdn Trust, Dept Histopathol, London, England
[3] Kings Coll London, Maternal & Fetal Res Unit, London WC2R 2LS, England
关键词
cardiac thrombosis; maternal death; pregnancy; thrombotic thrombocytopenic purpura;
D O I
10.1111/j.1447-0756.2012.01916.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In order to identify the cause of maternal deaths due to thrombotic thrombocytopenic purpura (TTP) and identify future preventative measures we retrospectively reviewed all maternal deaths due to TTP in London from 2003 to 2008 that were confirmed on post-mortem examination. There were three maternal deaths due to sudden cardiac arrest within 1, 5 and 2 days of presentation, respectively. Post-mortem findings revealed they all died with intramyocardial microvascular thrombosis, the thrombi being characteristically platelet rich (CD61+, fibrin-). Platelet thrombi in the coronary microvasculature are the cause of early sudden death in TTP in pregnancy. If TTP cannot be excluded in the differential diagnosis of thrombotic microangiopathies of pregnancy, then plasmapheresis should be instituted as a medical emergency. ADAMTS-13 levels are helpful in making the diagnosis, but results should not be awaited before instituting plasmapheresis.
引用
收藏
页码:347 / 350
页数:4
相关论文
共 8 条
[1]  
[Anonymous], 2007, 7 REPORT CONFIDENTIA
[2]   Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis [J].
Huusom, L. D. ;
Secher, N. J. ;
Pryds, O. ;
Whitfield, K. ;
Gluud, C. ;
Brok, J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2011, 118 (01) :1-5
[3]   Changes in health and disease of the metalloprotease that cleaves von Willebrand factor [J].
Mannucci, PM ;
Canciani, MT ;
Forza, I ;
Lussana, F ;
Lattuada, A ;
Rossi, E .
BLOOD, 2001, 98 (09) :2730-2735
[4]   HIGH-INCIDENCE OF RELAPSES IN THROMBOTIC THROMBOCYTOPENIC PURPURA - CLINICAL-STUDY OF 38 PATIENTS [J].
ROSE, M ;
ELDOR, A .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (03) :437-444
[5]   Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features [J].
Scully, Marie ;
Yarranton, Helen ;
Liesner, Ri ;
Cavenagh, Jamie ;
Hunt, Beverley ;
Benjamin, Sylvia ;
Bevan, David ;
Mackie, Ian ;
Machin, Samuel .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (05) :819-826
[6]   The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency [J].
Terrell, DR ;
Williams, LA ;
Vesely, SK ;
Lämmle, B ;
Hovinga, JAK ;
George, JN .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (07) :1432-1436
[7]  
WEINER CP, 1987, SEMIN HEMATOL, V24, P119
[8]  
WURZEL JM, 1979, NEW ENGL J MED, V301, P503